Our pioneering investor genotype test will forever change the way you think about investing.
Advances in DNA sequencing technology have ushered in a new era in personal informatics. Personal genetic screening now provide highly self-relevant insights that hold promise for motivating favorable changes in health-related behaviors. In addition to cancer genetics and the genetics of other diseases, researchers have identified many of the genes and brain systems that regulate decision making processes. Several studies have even shown that polygenic risk analysis can predict an individual’s vulnerability to stress-induced behaviors such as impulsivity, risk taking, gambling and impaired cognition.
nextSignals has taken the next step.
nextSignals detects genetic variants in 129 genes known to drive decision making and quantifies two key genomic signatures – emotion regulation and executive functioning. Data from over two hundred clinically significant gut microbiota are also examined for their potential to be modulated and reduce neuroinflammation. For investment decisions are remarkably susceptible to mind-body health.
Discover how your neurogenetic endowment combined with your mind-body health affects your investment decisions.
Emerging from the new discipline of genoeconomics, nextSignals is pioneering personalized methods for improving investment-related decision making using data from investors’ DNA sequence and gut microbial data. We have developed a proprietary relational database that links one’s individual genes to research studies that have reported correlations between genetic variation and financial decision making. Panels are clustered, odds ratios are calculated, and your individual strengths and weaknesses are revealed.
5-HTTLPR LL ALLELE CARRIER
“Long and strong,” I would say, as I held onto losing positions! I’ve learned that a genetic variation underpinning my natural optimism also reduces my penchant for processing negative market information.
Understanding how genes that regulated my serotonin levels contributed to an irrationally bullish bias helped me assume a more agnostic view of market events.
DRD4P SHORT ALLELE CARRIER
When making investment decisions, I often rely on “…one good reason.” Then I balance risk-return trade-offs and execute trading rules. I exercise discretion. I am not impulsive.
My neurogenetic analysis shed light on how my genes might be my “edge!” With healthy levels of dopamine, my investment process essentially amounts to supervising my algorithm.
TPH1 VARIANT CARRIER
I over-traded and overestimated my investing abilities. My interest in following daily fluctuations reduced both my portfolio performance and, frankly, my enjoyment of life.
Understanding my neurogenetics made one thing very clear: I needed to think slower. After I learned a few emotion regulation strategies, my average gains exceeded my average losses.
HTR1A G ALLELE HOMOZYGOTE
Volatility and I have never gotten along. A couple of consecutive downside days and I’m not sleeping. Apparently, my fear of portfolio losses is hard-wired into me.
Understanding how my genetics affects my loss aversion has allowed me to invest without being at the whim of my emotions. I’m sleeping much better now!